As opposed to cells undergoing a “silent” type of death like apoptosis, cells undergoing immunogenic cell death alarm the immune system by increasing surface expression of calreticulin and producing ATP and HMGB1, which trigger immune activation and initiate anti-tumor immunity. This evidence concerns the gene HMGB1 and neoplasm.